Age-related macular degeneration (AMD) was described for the first time in the 1840s and is
currently the leading cause of blindness for patients over 65 years in Western Countries …

The development of artificial intelligence (AI) and deep learning provided precise image
recognition and classification in the medical field. Ophthalmology is an exceptional …

Neovascular age-related macular degeneration (AMD) is described as abnormal
angiogenesis in the retina and the leaking of fluid and blood that generates a huge, dark …

Abstract Age-related Macular Degeneration (AMD), a retinal disease that affects the macula,
can be caused by aging abnormalities in number of different cells and tissues in the retina …

Variation in mesenchymal stromal cell (MSC) function depending on their origin is
problematic, as it may confound clinical outcomes of MSC therapy. Current evidence …

Purpose To examine whether changes in vision and hearing problems are associated with
changes in psychosocial outcomes (in terms of depressive symptoms, loneliness, and …

The introduction of intravitreal vascular endothelial growth factor (VEGF) inhibitor therapy
has revolutionized treatment for neovascular age-related macular degeneration (nAMD) …

Ocular angiogenesis, associated with diseases such as retinopathy of prematurity and
diabetic retinopathy, is a leading cause of irreversible vision loss. Herein, carbon …

The prevalence of visual impairment (VI) and age-related eye diseases has increased
dramatically with the growing aging population in mainland China. However, there is limited …

One of the most complicated eye disorders is age-related macular degeneration (AMD)
which is the leading cause of irremediable blindness all over the world in the elderly. AMD is …